Ads must not make false or misleading claims about the advertiser's or a competitor's products; comparative and 'proven' claims must be true and fairly qualified.
15 U.S.C. 1125(a)(1)(B)
What is Lanham Act - False Advertising and Competitor Disparagement (15 U.S.C. § 1125(a))?
Ads must not make false or misleading claims about the advertiser's or a competitor's products; comparative and 'proven' claims must be true and fairly qualified. Apply to comparative, superiority, test-result and competitor-referencing claims in any channel. This guide summarizes the supplied rule information for marketing review. Use the linked official source to confirm the current text, applicability and any exceptions
general_audience, general_adults_18plus, customers · All Industries · advertising marketing
Where does this rule apply?
United States
Which marketing channels are covered?
all_channels
When does this rule take effect?
2026-05-10
What does this rule require?
Ads must not make false or misleading claims about the advertiser's or a competitor's products; comparative and 'proven' claims must be true and fairly qualified.
How can marketing teams comply?
Apply to comparative, superiority, test-result and competitor-referencing claims in any channel.
What is Lanham Act - False Advertising and Competitor Disparagement (15 U.S.C. § 1125(a))?
Ads must not make false or misleading claims about the advertiser's or a competitor's products; comparative and 'proven' claims must be true and fairly qualified.
Who does this rule apply to?
general_audience, general_adults_18plus, customers · All Industries · advertising marketing
Claims that a prescription product is safer, more effective, the only or the first compared with other products require substantial evidence, normally head-to-head data, and must be accurately qualified; compounded drugs must not be marketed as FDA-approved or equivalent to a brand.
Request a free compliance scan of your homepage and book a time with Warrant.